RA Capital Management’s Obsidian Therapeutics OBX Stock Holding History
Bought
Maintained
Sold
Other funds holding OBX
RA Capital Management's OBX Position: Q3 2026 in Review
RA Capital Management opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 5,957,103 shares worth $81.8M. The stake represents 0.82% of the portfolio and ranks #29 among its holdings.
60 funds tracked by Wall St. Rank hold OBX as of Q3 2026.
- RA Capital Management held 5,957,103 shares of Obsidian Therapeutics worth $81.8M as of Q3 2026.
- Obsidian Therapeutics was a new RA Capital Management position in Q3 2026.
- Obsidian Therapeutics made up 0.82% of RA Capital Management's portfolio in Q3 2026, its #29 holding.
- 60 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.
Based on RA Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.